Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.

Autor:	Papp, Kim A.1 kapapp@probitymedical.com, Blauvelt, Andrew2, Bukhalo, Michael3, Gooderham, Melinda4,5, Krueger, James6, Lacour, Jean-Philippe7, Menter, Alan8, Philipp, Sandra9, Sofen, Howard10, Tyring, Stephen11, Berner, Beate R.12, Visvanathan, Sudha13, Pamulapati, Chandrasena13, Bennett, Nathan13, Flack, Mary13, Scholl, Paul13, Padula, Steven J.14, Krueger, James G15 (AUTHOR)
Zdroj:	New England Journal of Medicine. 4/20/2017, Vol. 376 Issue 16, p1551-1560. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu